The Europe Cardiovascular Digital Solutions Market should witness market growth of 4.1% CAGR during the forecast period (2022-2028).
Digital solutions are frequently used in healthcare to track the spread of infectious illnesses, monitor the quality of patient care, and evaluate clinical support. Utilizing cardiovascular digital solutions improves patient care through improved health monitoring, more individualized patient care, and decreased inefficiencies. The future of healthcare technology is bright because of digital innovations like wearable technology, telemedicine, and virtual reality technologies.
An example of a wearable gadget that could be utilized to assist in the management of CVD is a fitness tracker.Additionally,a home-based wearable constant ECG monitoring patch was successfully used by the mSToPS RCT to identify individuals with atrial fibrillation. The Apple Heart Study showed that the Apple Watch is only moderately good at detecting atrial fibrillation in its users. The EXPERT stands forExercise Prescription in Everyday Practice & Rehabilitation Training. Thistool illustrates a clinical electronic decision support tool.
EXPERT was developed by the European Association for Preventive Cardiology (EAPC) as an interactive decision tool that enables medical professionals to use an algorithm to compare their exercise recommendations to specified patient instances. Similarly,a customized EHR-based warning system could enhance the use of medication for heart failure that is prescribed according to guidelines, as demonstrated by the recent PROMPT-HF trial. The automatic interpretation of medical imaging data can also be helped by artificial intelligencedecision-support tools.
Pharmaceutical companies are also engaged in the development of effective medications to address the rise in cardiac problems. The European Medicines Agency has prepared a complete overview of the current guidelines and possibilities for participation during the development phase of a medicinal product (EMA). The agency aims to provide scientific and regulatory assistance for the development of application materials as well as a smooth validation and assessment procedure. Other nations, like the UK, Germany, andDenmark,where regulatory authorities have developed legislation relating to digital pharmaceuticals and digital health solutions, have seen a similar rise. In addition, the requirementfor digital solutionsis predicted to expand, given the present activity in this region and the rising need for such solutions.
The Germany market dominated the Europe Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,345.3 Million by 2028. The UK market is estimated to grow a CAGR of 3.3% during (2022-2028). Additionally, The France market would experience a CAGR of 4.9% during (2022-2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
Digital solutions are frequently used in healthcare to track the spread of infectious illnesses, monitor the quality of patient care, and evaluate clinical support. Utilizing cardiovascular digital solutions improves patient care through improved health monitoring, more individualized patient care, and decreased inefficiencies. The future of healthcare technology is bright because of digital innovations like wearable technology, telemedicine, and virtual reality technologies.
An example of a wearable gadget that could be utilized to assist in the management of CVD is a fitness tracker.Additionally,a home-based wearable constant ECG monitoring patch was successfully used by the mSToPS RCT to identify individuals with atrial fibrillation. The Apple Heart Study showed that the Apple Watch is only moderately good at detecting atrial fibrillation in its users. The EXPERT stands forExercise Prescription in Everyday Practice & Rehabilitation Training. Thistool illustrates a clinical electronic decision support tool.
EXPERT was developed by the European Association for Preventive Cardiology (EAPC) as an interactive decision tool that enables medical professionals to use an algorithm to compare their exercise recommendations to specified patient instances. Similarly,a customized EHR-based warning system could enhance the use of medication for heart failure that is prescribed according to guidelines, as demonstrated by the recent PROMPT-HF trial. The automatic interpretation of medical imaging data can also be helped by artificial intelligencedecision-support tools.
Pharmaceutical companies are also engaged in the development of effective medications to address the rise in cardiac problems. The European Medicines Agency has prepared a complete overview of the current guidelines and possibilities for participation during the development phase of a medicinal product (EMA). The agency aims to provide scientific and regulatory assistance for the development of application materials as well as a smooth validation and assessment procedure. Other nations, like the UK, Germany, andDenmark,where regulatory authorities have developed legislation relating to digital pharmaceuticals and digital health solutions, have seen a similar rise. In addition, the requirementfor digital solutionsis predicted to expand, given the present activity in this region and the rising need for such solutions.
The Germany market dominated the Europe Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,345.3 Million by 2028. The UK market is estimated to grow a CAGR of 3.3% during (2022-2028). Additionally, The France market would experience a CAGR of 4.9% during (2022-2028).
Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.
Scope of the Study
By Service Type
- Unobtrusive Testing
- CVD Health Informatics
- Cardiac Rehab Programs
- Others
By End-use
- Hospitals & Clinics
- Ambulatory Care Centers
- Others
By Deployment
- Cloud-Based
- On-premise
By Components
- Devices
- Software
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc. (Hill-Rom Holdings Inc) (Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cardiovascular Digital Solutions Market, by Service Type
1.4.2 Europe Cardiovascular Digital Solutions Market, by End-use
1.4.3 Europe Cardiovascular Digital Solutions Market, by Deployment
1.4.4 Europe Cardiovascular Digital Solutions Market, by Components
1.4.5 Europe Cardiovascular Digital Solutions Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Analyst's Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2022, Nov) Leading Players
Chapter 4. Europe Cardiovascular Digital Solutions Market by Service Type
4.1 Europe Unobtrusive Testing Market by Country
4.2 Europe CVD Health Informatics Market by Country
4.3 Europe Cardiac Rehab Programs Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe Cardiovascular Digital Solutions Market by End-use
5.1 Europe Hospitals & Clinics Market by Country
5.2 Europe Ambulatory Care Centers Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Cardiovascular Digital Solutions Market by Deployment
6.1 Europe Cloud-Based Market by Country
6.2 Europe On-premise Market by Country
Chapter 7. Europe Cardiovascular Digital Solutions Market by Components
7.1 Europe Devices Market by Country
7.2 Europe Software Market by Country
Chapter 8. Europe Cardiovascular Digital Solutions Market by Country
8.1 Germany Cardiovascular Digital Solutions Market
8.1.1 Germany Cardiovascular Digital Solutions Market by Service Type
8.1.2 Germany Cardiovascular Digital Solutions Market by End-use
8.1.3 Germany Cardiovascular Digital Solutions Market by Deployment
8.1.4 Germany Cardiovascular Digital Solutions Market by Components
8.2 UK Cardiovascular Digital Solutions Market
8.2.1 UK Cardiovascular Digital Solutions Market by Service Type
8.2.2 UK Cardiovascular Digital Solutions Market by End-use
8.2.3 UK Cardiovascular Digital Solutions Market by Deployment
8.2.4 UK Cardiovascular Digital Solutions Market by Components
8.3 France Cardiovascular Digital Solutions Market
8.3.1 France Cardiovascular Digital Solutions Market by Service Type
8.3.2 France Cardiovascular Digital Solutions Market by End-use
8.3.3 France Cardiovascular Digital Solutions Market by Deployment
8.3.4 France Cardiovascular Digital Solutions Market by Components
8.4 Russia Cardiovascular Digital Solutions Market
8.4.1 Russia Cardiovascular Digital Solutions Market by Service Type
8.4.2 Russia Cardiovascular Digital Solutions Market by End-use
8.4.3 Russia Cardiovascular Digital Solutions Market by Deployment
8.4.4 Russia Cardiovascular Digital Solutions Market by Components
8.5 Spain Cardiovascular Digital Solutions Market
8.5.1 Spain Cardiovascular Digital Solutions Market by Service Type
8.5.2 Spain Cardiovascular Digital Solutions Market by End-use
8.5.3 Spain Cardiovascular Digital Solutions Market by Deployment
8.5.4 Spain Cardiovascular Digital Solutions Market by Components
8.6 Italy Cardiovascular Digital Solutions Market
8.6.1 Italy Cardiovascular Digital Solutions Market by Service Type
8.6.2 Italy Cardiovascular Digital Solutions Market by End-use
8.6.3 Italy Cardiovascular Digital Solutions Market by Deployment
8.6.4 Italy Cardiovascular Digital Solutions Market by Components
8.7 Rest of Europe Cardiovascular Digital Solutions Market
8.7.1 Rest of Europe Cardiovascular Digital Solutions Market by Service Type
8.7.2 Rest of Europe Cardiovascular Digital Solutions Market by End-use
8.7.3 Rest of Europe Cardiovascular Digital Solutions Market by Deployment
8.7.4 Rest of Europe Cardiovascular Digital Solutions Market by Components
Chapter 9. Company Profiles
9.1 Apple, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 General Electric Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Koninklijke Philips N.V.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Verily Life Sciences LLC (Alphabet, Inc.)
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 iRhythm Technologies, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Research & Development Expense
9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.8 AliveCor, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Partnerships, Collaborations, and Agreements:
9.8.2.2 Product Launches and Product Expansions:
9.9 Cardiotrack
9.9.1 Company Overview
9.10. HeartFlow, Inc.
9.10.1 Company Overview
Companies Mentioned
- Apple, Inc.
- General Electric Company
- Koninklijke Philips N.V.
- Verily Life Sciences LLC (Alphabet, Inc.)
- iRhythm Technologies, Inc.
- Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
- eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
- AliveCor, Inc.
- Cardiotrack
- HeartFlow, Inc.
Methodology
LOADING...
